CBPO - China Biologic Products Holdings, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Currency in USD

Valuation measures

Market cap (intra-day) 54.16B
Enterprise value 33.09B
Trailing P/E 27.36
Forward P/E 120.47
PEG ratio (5-yr expected) 12.29
Price/sales (ttm)7.75
Price/book (mrq)2.40
Enterprise value/revenue 35.76
Enterprise value/EBITDA 614.43

Trading information

Stock price history

Beta (5Y monthly) 0.58
52-week change 311.85%
S&P500 52-week change 36.72%
52-week high 3119.44
52-week low 392.22
50-day moving average 3107.71
200-day moving average 3111.06

Share statistics

Avg vol (3-month) 3113.33k
Avg vol (10-day) 3169.08k
Shares outstanding 538.46M
Float 14.18M
% held by insiders 154.17%
% held by institutions 140.49%
Shares short (14 Jun 2020) 4454.33k
Short ratio (14 Jun 2020) 44.68
Short % of float (14 Jun 2020) 42.04%
Short % of shares outstanding (14 Jun 2020) 41.18%
Shares short (prior month 14 May 2020) 4426.85k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2019
Most-recent quarter (mrq)30 Mar 2020

Profitability

Profit margin 28.80%
Operating margin (ttm)35.00%

Management effectiveness

Return on assets (ttm)5.84%
Return on equity (ttm)9.80%

Income statement

Revenue (ttm)536.55M
Revenue per share (ttm)13.96
Quarterly revenue growth (yoy)25.30%
Gross profit (ttm)329.08M
EBITDA 214.26M
Net income avi to common (ttm)152.81M
Diluted EPS (ttm)3.95
Quarterly earnings growth (yoy)41.60%

Balance sheet

Total cash (mrq)991.63M
Total cash per share (mrq)25.77
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)10.51
Book value per share (mrq)45.11

Cash flow statement

Operating cash flow (ttm)272.92M
Levered free cash flow (ttm)248.93M